Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Sep;7(3):308-315.
doi: 10.1136/bmjspcare-2016-001146. Epub 2017 Feb 6.

Key issues affecting quality of life and patient-reported outcomes in prostate cancer: an analysis conducted in 2128 patients with initial psychometric assessment of the prostate cancer symptom scale (PCSS)

Affiliations

Key issues affecting quality of life and patient-reported outcomes in prostate cancer: an analysis conducted in 2128 patients with initial psychometric assessment of the prostate cancer symptom scale (PCSS)

Pavlos Msaouel et al. BMJ Support Palliat Care. 2017 Sep.

Abstract

Objective: Evidence-based quality of life (QL) questionnaires require the identification of issues of importance to patients. The primary aim of this study was to inform providers on patient-expressed issues while enhancing the content validity of instruments assessing QL and patient-reported outcomes (PROs) in prostate cancer. The study provided additional psychometric properties for the new PRO and QL instrument, the Prostate Cancer Symptom Scale (PCSS).

Methods: An anonymous web-based survey of 2128 patients with prostate cancer was conducted with patients rating 18 QL items on a five-point scale.

Results: Most respondents (74%) were aged 55-74 years, had early stage disease at diagnosis (81%) and were diagnosed within 2 years of the survey (81%). The top five-rated issues were: overall QL, ability to perform normal activities, maintaining independence, ability to sleep and not being a burden. These items were ranked as either 'very important' or 'important' by at least 88% of patients. None of the most highly ranked issues were symptoms. Instead, the highest ranked items were global issues reflecting the impact of symptoms on patients. In addition to the enhanced content validity findings, good reliability results and initial support for construct validity are reported for the PCSS.

Conclusions: This is the largest survey providing patient-expressed background for content validity for QL and PRO measures. The findings of this study should aid development of newer practical questionnaires, such as the PCSS, which can be adapted to electronic platforms enhancing rapid and accurate PRO and QL evaluation.

Keywords: PCSS; Quality of life evaluation; patient reported outcomes; prostate cancer; psychometric properties.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

    1. PROQOLID [Online Patient-Reported Outcome and Quality of Life Instruments Database] Secondary PROQOLID [Online Patient-Reported Outcome and Quality of Life Instruments Database] http://www.proqolid.org/
    1. US Department of Health and Human Services (USDHHS); Guidance for industry. Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. 2009 Dec;2009 Secondary US Department of Health and Human Services (USDHHS); Guidance for industry. Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. http://www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdf. - PMC - PubMed
    1. Rnic K, Linden W, Tudor I, Pullmer R, Vodermaier A. Measuring symptoms in localized prostate cancer: a systematic review of assessment instruments. Prostate cancer and prostatic diseases. 2013;16:111–22. - PubMed
    1. Roth AJ, Weinberger MI, Nelson CJ. Prostate cancer: psychosocial implications and management. Future oncology. 2008;4:561–8. - PMC - PubMed
    1. Ochayon L, Zelker R, Kaduri L, Kadmon I. Relationship between severity of symptoms and quality of life in patients with breast cancer receiving adjuvant hormonal therapy. Oncology nursing forum. 2010;37:E349–58. - PubMed

Publication types